Drosophila insulin-like peptides (dILPs) regulate part of the signaling pathway that helps keep organs growing in proportion during development.
Drosophila insulin-like peptides (dILPs) regulate part of the signaling pathway that helps keep organs growing in proportion during development.
Although fully organized patient-run trials are still few and far between, patients are taking a more active role in clinical research.
| March 1, 2013
Meet some of the people featured in the March 2013 issue of The Scientist.
Patients are sidestepping clinical research and using themselves as guinea pigs to test new treatments for fatal diseases. Will they hurt themselves, or science?
During development, communication between organs determines their relative final size.
Scientist? Filmmaker? Alexis Gambis welcomes both labels.
The first human trial of a treatment using induced pluripotent stem cells has received conditional approval from an institutional review board in Japan.
New research adds to an emerging picture of the changes that global warming and thinning ice are wreaking on the marine ecosystems at the top of the world.
Scenes from a research trip, where researchers peered beneath the ice to shine a light on the emerging picture of a changing Arctic Ocean